Dr. David Holden Henry III, MD

Dr. Henry practices at Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Henry's NPI, 1063406411, was assigned on August 31, 2005. Dr. Henry graduated from Perelman School of Medicine - Philadelphia in 1975. Dr. Henry holds Pennsylvania license MD018597E.

Dr. Henry's primary practice is Pennsylvania Hospital, at 800 Spruce Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 829-3000.

Dr. Henry's primary practice is Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Henry is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Henry to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Henry practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Henry's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Henry is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Henry's licenses on file in 2 states: Pennsylvania and Florida.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT) and immune deficiency disease among the conditions Dr. Henry treats.

CMS data shows 2,067 Medicare services from Dr. Henry across 8 procedure codes in 2024, for 594 Medicare patients. Medicare paid $114,179 for them.

CMS counts 594 Medicare patients who saw Dr. Henry in 2024. The largest group is 75 to 84, with 240 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Henry's median patient age at 71, with 56% women.

In 2024, Dr. Henry wrote 825 Medicare Part D claims for 197 patients. 65% of them were for generic drugs. CMS names the drug for 527 of them, across 19 drugs with 11 or more claims each, at $1,371,936 in total drug cost. In 2023, CMS named 447 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Henry for performance year 2024, reported as part of a group. Dr. Henry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Henry as offering telehealth.

Dmand AI links 105 papers to Dr. Henry, published from 2004 to 2023. 2017 was the busiest year, with 5. The most frequent topics are Anemia, Erythropoietin and Recombinant Proteins. Dr. Henry has published most often in J Clin Oncol. Dr. Henry's most frequent co-authors are Lee Ratner, MD, Ariela Noy, MD and Juan C. Ramos, MD.

Dmand AI links Dr. Henry to 6 clinical trials, 2 of them phase 1 studies. Conditions studied include AIDS-related Kaposi sarcoma, Anus Neoplasms and Lymphoma. AIDS Malignancy Consortium sponsors the most, 3. Open Payments lists research payments to Dr. Henry that name 1 trial.

CMS Open Payments shows 109 general payments to Dr. Henry from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Amgen Inc. paid the most, $27,894. It also lists 11 research payments totaling $21,100 from 2016 to 2024, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Henry, most recently America's Top Doctors in 2014.

Dr. Henry graduated from Perelman School of Medicine - Philadelphia in 1975. Dr. Henry is a member of ASCO and ASH.

Dr. Henry is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.